LGALS3BP and choriocarcinoma: Meanwhile, the sera concentration of LGALS3BP was higher in MTX-resistant patients than MTX-sensitive patients indicating LGALS3BP may be a molecular mark to predict MTX-resistance in choriocarcinoma.